Investment Team
Health & TechBio
We believe the next decade will be transformational for healthcare and life sciences.
Advances in computing, technology, and biology are compounding at a dizzying pace. The case for change has never been clearer, yet healthcare remains one of the least digitized sectors of the economy.
We get excited about founders who are laying the foundation for a more connected and data-driven ecosystem. Those enabling a future that is more personalized, preventative, and predictive.
If you’re working on core healthcare or life sciences infrastructure or solutions that can dramatically move the needle on access, costs, or outcomes in areas such as home health, back office automation, clinical trials tech, AI-enabled R&D, pharma and provider software tools, let’s talk!
Initial ticket size
€300K - 2M
We invest in
Pre-Seed & Seed stage startups
Health & TechBio Focused
We have one of the largest and most exciting digital health & TechBio portfolios in Europe. We back bold, visionary founders at the earliest stages of their journey and aspire to be your first call.
Relevant, Real-World Experience
We have built and scaled health & bio startups, practiced medicine, and studied physics, biology & engineering. We get what you do, the “chaos” of the earliest stages, and are obsessed with helping you build, scale, and succeed.
Large & Expanding Network
From our advisors to VCs, experienced founders, providers, payors, and pharma, we connect you with the people you need to succeed. If we don’t have a connection yet, we will hustle with you to find it.
“Intros to players in our market helped us get to product-market fit much faster which then led to us landing 11M in Series A follow-on. Since then, we’ve grown the team to 60+ people.”
Founder & CEO, Remberg
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
This is some text inside of a div block.
From The Blog
Femtech Investment: Analysis and Key Drivers of the Industry
VCs invested $1 billion in early-stage femtech in 2022. Speedinvest's Daria Gherghelas and Estelle Botbol untangle the data and introduce 440-plus femtech startups.
Non-Dilutive Funding For Startups All Across Europe
Speedinvest's Estelle Botbol explains what non-dilutive funding is and shares non-dilutive funding options for startups from all across Europe.
Discover more articles like these on the Speedinvest Blog
Tell us about your startup
Submit Pitch.svg)
“It was so clear and gratifying that Speedinvest had high conviction in Fertifa’s vision and team from the start. The firm's deep expertise and collective years' of experience in both health and fintech means they're the ideal fit for us and our ambitions. Additionally, their culture of "ride or die" support, hustle and no BS makes us incredibly grateful to count them as a partner.”
Director, Fertifa
"Speedinvest is a committed partner, passionate about our cause and proactive on many fronts, from strategy, to hiring and PR. Thank you Markus, Yang, and the rest of the Speedinvest team for helping us win."
Founder & CEO, Opal
"We didn't just want capital, we wanted investors who are aligned with our values and share our vision for the future of healthcare. Speedinvest have been that partner from day 1."
Co-Founder, Doccla
“From the first meeting, we knew we wanted Speedinvest as partners. Their experience in the European start-up ecosystem is unparalleled, which when combined with their support and network, makes an attractive USP. But it is the long-term relationships with the team that make Speedinvest a truly valuable partner."
CEO & Founder, Seqera Labs
"Speedinvest backed us from the very beginning of our journey and have never failed to show up with their network, advice, and conviction. Six years and counting with them behind us, and I hope they are with us through the IPO."
Founder & CEO, Second Nature